Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-05-13 Sale |
2024-05-15 5:20 pm |
Evolus Inc. | EOLS | GILL DAVID N Director |
10,361 | $12.64 | $131,010 | 33,964 (Direct) |
View |
| 2022-05-13 Sale |
2022-05-17 6:49 pm |
Evolus Inc. | EOLS | GILL DAVID N Director |
10,313 | $13.35 | $137,664 | 29,568 (Direct) |
View |
| 2021-10-05 Sale |
2021-10-06 7:41 pm |
Strongbridge Biopharma plc | SBBP | GILL DAVID N Director |
78,058 | $0 | $0 | 0 (Direct) |
View |
| 2021-01-19 Sale |
2021-01-20 4:16 pm |
Y-mAbs Therapeutics Inc. | YMAB | GILL DAVID N Director |
2,000 | $46.52 | $93,045 | 24,000 (Direct) |
View |
| 2020-11-18 Sale |
2020-11-20 4:15 pm |
Y-mAbs Therapeutics Inc. | YMAB | GILL DAVID N Director |
2,000 | $45.77 | $91,530 | 26,000 (Direct) |
View |
| 2020-11-03 Sale |
2020-11-05 5:51 pm |
Y-mAbs Therapeutics Inc. | YMAB | GILL DAVID N Director |
4,000 | $45 | $180,000 | 28,000 (Direct) |
View |
| 2020-09-24 Purchase |
2020-09-28 07:48 am |
Strongbridge Biopharma plc | SBBP | GILL DAVID N Director |
8,000 | $2.13 | $17,040 | 74,896 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-03-07 Option Award |
2025-03-11 6:54 pm |
N/A 2035-03-07 |
Evolus Inc. | EOLS | GILL DAVID N Director |
18,510 | $0 | 52,474 (Direct) |
View |
| 2024-06-11 Option Award |
2024-06-13 9:00 pm |
N/A 2034-06-11 |
Y-mAbs Therapeutics Inc. | YMAB | GILL DAVID N Director |
18,040 | $0 | 20,370 (Direct) |
View |
| 2024-02-07 Option Award |
2024-02-09 6:37 pm |
N/A 2034-02-07 |
Evolus Inc. | EOLS | GILL DAVID N Director |
15,841 | $0 | 53,702 (Direct) |
View |
| 2023-06-08 Option Award |
2023-06-09 6:01 pm |
N/A 2033-06-08 |
Y-mAbs Therapeutics Inc. | YMAB | GILL DAVID N Director |
16,280 | $0 | 16,280 (Direct) |
View |
| 2023-01-27 Option Award |
2023-01-31 8:41 pm |
N/A 2033-01-27 |
Evolus Inc. | EOLS | GILL DAVID N Director |
20,082 | $0 | 49,650 (Direct) |
View |
| 2022-07-15 Option Award |
2022-07-19 1:20 pm |
N/A 2032-07-14 |
Y-mAbs Therapeutics Inc. | YMAB | GILL DAVID N Director |
16,000 | $0 | 16,000 (Direct) |
View |
| 2022-01-24 Option Award |
2022-01-26 9:01 pm |
N/A 2032-01-24 |
Evolus Inc. | EOLS | GILL DAVID N Director |
38,295 | $0 | 62,608 (Direct) |
View |
| 2021-10-01 Tax Withholding |
2021-10-05 7:21 pm |
N/A N/A |
Strongbridge Biopharma plc | SBBP | GILL DAVID N Director |
17,763 | $2.06 | 78,058 (Direct) |
View |
| 2021-06-10 Option Award |
2021-06-14 5:03 pm |
2021-07-10 2031-06-10 |
Y-mAbs Therapeutics Inc. | YMAB | GILL DAVID N Director |
16,000 | $0 | 16,000 (Direct) |
View |
| 2021-05-18 Option Award |
2021-05-18 7:10 pm |
N/A N/A |
Strongbridge Biopharma plc | SBBP | GILL DAVID N Director |
40,000 | $0 | 95,821 (Direct) |
View |
| 2021-05-14 Tax Withholding |
2021-05-17 6:29 pm |
N/A N/A |
Strongbridge Biopharma plc | SBBP | GILL DAVID N Director |
19,075 | $2.35 | 55,821 (Direct) |
View |
| 2021-02-05 Option Award |
2021-02-09 5:13 pm |
N/A N/A |
Evolus Inc. | EOLS | GILL DAVID N Director |
19,313 | $0 | 24,313 (Direct) |
View |
| 2021-01-19 Exercise |
2021-01-20 4:16 pm |
N/A N/A |
Y-mAbs Therapeutics Inc. | YMAB | GILL DAVID N Director |
2,000 | $11.16 | 24,000 (Direct) |
View |
| 2021-01-19 Exercise |
2021-01-20 4:16 pm |
N/A 2028-04-24 |
Y-mAbs Therapeutics Inc. | YMAB | GILL DAVID N Director |
2,000 | $0 | 24,000 (Direct) |
View |
| 2020-11-18 Exercise |
2020-11-20 4:15 pm |
N/A N/A |
Y-mAbs Therapeutics Inc. | YMAB | GILL DAVID N Director |
2,000 | $11.16 | 26,000 (Direct) |
View |
| 2020-11-18 Exercise |
2020-11-20 4:15 pm |
N/A 2028-04-24 |
Y-mAbs Therapeutics Inc. | YMAB | GILL DAVID N Director |
2,000 | $0 | 26,000 (Direct) |
View |
| 2020-11-03 Exercise |
2020-11-05 5:51 pm |
N/A N/A |
Y-mAbs Therapeutics Inc. | YMAB | GILL DAVID N Director |
4,000 | $11.16 | 28,000 (Direct) |
View |
| 2020-11-03 Exercise |
2020-11-05 5:51 pm |
N/A 2028-04-24 |
Y-mAbs Therapeutics Inc. | YMAB | GILL DAVID N Director |
4,000 | $0 | 28,000 (Direct) |
View |
| 2020-09-03 Tax Withholding |
2020-09-04 4:28 pm |
N/A N/A |
Strongbridge Biopharma plc | SBBP | GILL DAVID N Director |
23,104 | $3.61 | 66,896 (Direct) |
View |
| 2020-06-23 Option Award |
2020-06-24 4:46 pm |
2020-07-23 2030-06-23 |
Y-mAbs Therapeutics Inc. | YMAB | GILL DAVID N Director |
16,000 | $0 | 16,000 (Direct) |
View |
| 2020-05-14 Option Award |
2020-05-15 4:47 pm |
N/A N/A |
Strongbridge Biopharma plc | SBBP | GILL DAVID N Director |
40,000 | $0 | 90,000 (Direct) |
View |